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Objectives: The aim of this study was to assess whether non-speciﬁc clinical signs or biological
results can identify patients with a high probability of infective endocarditis (IE) to improve outcome.
Patients and methods: All patients tested for IE were included in a cohort and classiﬁed according
to the modiﬁed Duke criteria. Patients with rejected endocarditis served as controls. Univariate and
multivariate analyses were performed, and a score was calculated by adding 1 when a variable inde-
pendently associated with IE (excluding major Duke criteria) was present and 0 when the variable
was absent. A second score for patients with prior valvular damage (PVD) was also used. Scores were
evaluated using the ROC curve method.
Results: IE was diagnosed in 402 of 2039 participants (19.7%). By multivariate analysis, PVD, fever,
emboli, stroke, splenomegaly, ﬁnger clubbing, leucocytosis and erythrocyte sediment rate >50
were independently associated with IE. The rate of IE increased signiﬁcantly from 4% (10/254) for a
score of 0 to 83% (10/12) for a score of 6 in all patients, and from 9.5% (23/241) to 100% (10/10)
in patients with PVD. The area under the ROC curve was 0.75 for the ﬁrst score and 0.7 for the second.
In a prospective study of 117 patients with suspicion of IE, the proportion of conﬁrmed IE was 19%
and the area under the ROC curve was 0.72.
Conclusions: This simple score can be used to identify patients with a high probability of IE, in the
emergency room or on admission, to speed up diagnosis, or to initiate empirical antimicrobial therapy
without replacing the modiﬁed Duke criteria.
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Introduction
Infective endocarditis (IE) remains associated with high morbid-
ity and mortality, despite progress in diagnosis and treatment.
One difﬁculty encountered in the diagnosis of endocarditis is
related to the fact that all or some of the classical clinical
manifestations of endocarditis such as bacteraemia, fungaemia,
evidence of active valvulitis, emboli or immunological vascular
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present. This may delay the diagnosis and subsequently the treat-
ment, making the prognosis poorer. In addition, major modiﬁed
Duke criteria, such as positive blood culture for IE or positive
endocardial involvement, which are indispensable to classify
patients, are not usable on admission to identify patients at high
risk of endocarditis when this infection is suspected because
they can be used only at the end of an investigation, requiring
several days for completion.
1 In addition, this investigation
requires imaging and microbiological resources that are not
always available, especially in developing countries.
The prognosis of IE could be further improved if it was poss-
ible to identify earlier patients at high risk for IE when such
infection is suspected in order to shorten the interval between
such suspicion and therapy. Since 1994, we have used a diag-
nostic kit for IE, which has made it possible to evaluate the inci-
dence of IE in a cohort of patients with suspected IE.
2
Therefore, based on these data, we performed the present study
to assess whether or not clinical signs and biological results
available in the emergency room could enable us to identify
patients at high risk of IE.
Patients and methods
A structured standardized questionnaire was used, by a resident in
infectious diseases based in the microbiology laboratory, to prospec-
tively collect the following data on all patients with suspicion of
IE subjected to the diagnostic kit: age, sex, signs and symptoms,
duration of symptoms, biological results, history of antimicrobial
therapy for the current illness that prompted the patient to seek
medical attention, antecedent disease, predisposing factors for IE
including systemic disease, prosthetic valve, intravenous drug abuse,
dental or surgical manipulation, treatment received during the
course of hospitalization and outcome.
Each patient consulting or hospitalized in any of the Assistance
Publique of Marseille hospitals (AP-HM) with suspicion of IE
underwent testing guided by the diagnostic kit after informed
consent was obtained.
2 Each kit contained written guidelines for
testing requirements and the informed consent form. The kit con-
sisted of three units. The ﬁrst, to be used immediately, included a
set of two blood culture vials for aerobic and anaerobic cultures
(Bactec
w, Becton–Dickinson, Sparks, MD, USA), and a tube to
collect a serum sample used for rheumatoid factor detection
(Rapitex
w RF, Dade Behring Inc., Newark, NJ, USA) and estimation
of speciﬁc antibodies directed against Coxiella burnetii, Bartonella
spp., Brucella spp., Chlamydia spp., Mycoplasma pneumoniae,
Legionella pneumophila and Aspergillus spp.
3–9 The second and
third units of the diagnosis kit each contained a set of two blood
culture vials to be used 2 and 4 h, respectively, after the ﬁrst one.
All diagnostic kits were processed at the Microbiology Laboratory
of La Timone Hospital (AP-HM).
Data on patients with suspicion of IE who are subjected to the
diagnostic kit are routinely prospectively collected, and were used
for this epidemiological study. The approval of our Institutional
Research Ethics Committee was not required.
Bacterial identiﬁcation was performed according to the clinical
microbiology procedures handbook.
10 When usual methods were
inconclusive, PCR ampliﬁcation followed by sequencing of the 16
rDNA gene was performed.
11–13 DNA extracts were prepared from
suspect colonies for use as templates in PCR ampliﬁcation using
QIAmp Blood Kit (Qiagen, Hilden, Germany), according to the
manufacturer’s instructions.
14
Valvular surgical samples included valvular and periprosthetic
tissue, vegetations, valve prostheses and tissue fragments obtained
from abscess debridement. A smear of each sample was prepared
and stained using Gram and Ziehl methods. As described above for
bacterial identiﬁcation, a part of each tissue sample was inoculated
into brain heart medium and blood agar medium as well as cell
culture. A DNA extract, suitable for use as a template for PCR as
above, was prepared from each sample using a QIAmp Tissue Kit
(Qiagen), according to the manufacturer’s instructions.
14 For patho-
logical examinations, formalin-ﬁxed and parafﬁn-embedded tissue
samples were cut to a thickness of 5 mm and stained with routine
haematoxylin–eosin. Valvular tissue examination enabled us to
recognize consistent patterns of tissue damage associated with
IE, namely vegetation and valvular inﬂammation.
15 Special stains
were used to detect bacteria and fungi: Giemsa, Brown-Brenn and
Brown-Hopps tissue Gram, periodic acid-Schiff, Gimenez,
16
Grocott-Gomori methenamine silver, Ziehl-Neelsen and Warthin-
Starry.
17,18
The modiﬁed Duke criteria were used to deﬁne cases of endo-
carditis.
19 All patients assessed as having possible IE received
antibiotic treatment if they had one major Duke criterion or trans-
oesophageal echocardiographic abnormalities or a microbiologically
proven infection. All cases of possible IE were followed up for a
minimum period of 6 months.
Deﬁnitions
Leucocytosis was deﬁned as a white blood cell count .10 000 mm
23
(10   10
9 L
21). Anaemia was deﬁned as haemoglobin level ,13 g/dL
for men and ,12 g/dL for women, and thrombocytopenia as platelet
count ,150 000 mm
23.
Cohort study
All patients with a suspicion of IE were included in a cohort study
whose objective was to assess the clinical and biological features
associated and/or predictive of IE. Criteria used to reject the diagno-
sis of IE were the modiﬁed Duke criteria proposed by Li et al.
19
Patients with rejected endocarditis served as control patients, and
patients with possible endocarditis were not included in the study.
Major modiﬁed Duke criteria (positive blood culture and positive
echocardiogram for IE) were excluded from the analysis since those
criteria had been used to classify the patients.
To validate the scoring system, a prospective study was
implemented in November 2007. The score was calculated for all
patients with a suspicion of IE for whom a diagnostic kit was used
and the preliminary results are presented in this article.
Data analysis
The results of the diagnosis kits were considered redundant when
more than one kit was used for the diagnosis of one episode of IE
and those results were deleted from the database.
An EXCEL spread sheet was used to enter clinical and biologi-
cal data. Univariate and multivariate analyses were performed by
using SPSS software version 10 (Chicago, IL, USA). Scores were
calculated by adding 1 each time a variable signiﬁcantly associated
with IE in the logistic regression analysis was present and 0 when
the variable was absent. x
2 for trend was calculated, as well as the
odds ratio, with the Statcalc program of EpiInfo version 3.4.1
(Centers for Disease Control and Prevention, Atlanta, GA, USA),
for each score level compared with the score of 0. Positive pre-
dictive values (PPVs) and negative predictive values (NPVs) were
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calculator type 2 (http://www.healthcare.ubc.ca/calc/bayescalc2.
html). Due to the small number of patients with the highest scores,
scores from 6 to 8 were combined in the ﬁrst scoring system and
from 5 to 8 in the second scoring system. ROC curves were drawn
with SPSS for Windows (version 10.0.5).
Results
During the study period from 1 October 1999 to 31 January
2006, a total of 1870 patients aged from 4 to 103 years admitted
at any of the Assistance Publique-Ho ˆpitaux de Marseille health-
care facilities with clinical suspicion of IE were subjected to the
diagnostic kit and included in the study. These patients were
subjected to 2039 diagnosis kits (1.09 kit/patient). The highest
proportion of diagnosis kits was sent by the cardiology and
cardiac surgery services (48.3%, 985) followed by the internal
medicine services (21.3%, 434). The characteristics of the patients
with a suspicion of IE are shown in Table 1. The mean age of the
patients was 62 years, 60% were male, 59.4% had prior valvular
damage (PVD), 11.4% had a bio-prosthesis, 12.3% a mechanical
prosthesis and 13% a pacemaker. The most frequently damaged
valve was the mitral valve (37.3%), followed by the aortic valve
(34%) and the tricuspid valve (4.3%).
As categorized by the modiﬁed Duke criteria, following the
use of the diagnostic kits and the performance of echocardio-
grams, a diagnosis of deﬁnite IE was made for 19.7%
(402/2039) of the patients and of possible IE for 3.2% (66/2039)
of the patients and a diagnosis of IE was rejected in 77% (1571/
2039). Seventeen patients presented two episodes of IE and one
patient presented four episodes.
Following the exclusion of the 66 patients with possible
endocarditis, 1152 of the remaining patients had PVD (this
category included patients with prosthetic heart valves, a pace-
maker or congenital heart disease) and 30.2% of them (348)
were diagnosed with IE. With regard to the presence of foreign
bodies, the highest proportion of IE was diagnosed in patients
with pacemakers (37.5%, 94/251), followed by patients with
bio-prostheses (30.5%, 68/223) and patients with mechanical
prostheses (19.7%, 47/239).
Two hundred and eighty patients (69.7%) with IE were male
and their ages ranged from 4 to 95 years with a mean age of
63 years +17 and a median age of 67. The proportion of
patients with IE was signiﬁcantly higher from cardiology
services (28.3%, 279/985) than from internal medicine services
(6.5%, 28/434) [relative risk (RR): 1.4, 95% conﬁdence interval
(95% CI): 1.35–1.5, P , 0.0000001].
Of all IE, 88.8% (357/402) were microbiologically docu-
mented. The 15 microorganisms most commonly considered
responsible for endocarditis were as follows: Staphylococcus
aureus (17.2%, 69/402), Streptococcus bovis (13.4%, 54/402),
Staphylococcus epidermidis (8.5%, 34/402), Enterococcus
faecalis (8%, 32/402), C. burnetii (5%, 20/402), Streptococcus mitis
(3.2%, 13/402), Escherichia coli (2%, 8/402), Streptococcus
agalactiae (1.5%, 6/402), Streptococcus oralis (1.5%, 6/402),
Bartonella spp. (1.5%, 6/402), Candida spp. (1.5%, 6/402),
Staphylococcus lugdunensis (1.5%, 6/402), Streptococcus
anginosus (1.2%, 5/402), Streptococcus sanguinis (1%, 4/402)
and Corynebacterium spp. (1%, 4/402).
Retrospective cohort study
The purpose of the cohort study was to assess which clinical signs
and biological results were associated with or predictive of IE in
order to identify patients at high risk of IE at the time of admis-
sion. When, by univariate analysis, patients with endocarditis
were compared with patients with rejected endocarditis, non-
speciﬁc clinical signs and biological results including male sex,
hepatomegaly, splenomegaly, stroke, emboli, spondylodiscitis,
diarrhoea, anaemia, leucocytosis, thrombocytopenia and erythro-
cytes sediment rate (ESR) . 50 were signiﬁcantly associated with
and predictive of IE (Tables 2 and 3). Spondylodiscitis was
excluded as the diagnosis of this clinical manifestation requires
additional imaging procedures.
Therefore, a second analysis was performed in which only
variables corresponding to clinical signs and biological results
available or present on admission and signiﬁcantly associated
with IE in univariate analysis were used in a model tested
by binary logistic regression analysis. By multivariate
analysis, male sex, PVD, fever, emboli, stroke, splenomegaly,
ﬁnger clubbing, leucocytosis and ESR . 50 were independently
associated with IE, and the model ﬁtted the observed data
according to the Hosmer–Lemeshow goodness-of-ﬁt test
(Table 4).
Scoring system
We then designed a very simple scoring system in order to quan-
tify the probability for a given patient to have IE according to
the number of predictive factors present identiﬁed by multi-
variate analysis. The score was calculated by adding 1 each time
a predictive factor was present and 0 when it was absent.
Table 1. Characteristics of the patients with suspicion of IE
included in the study
Characteristic Number
Sex, male 1222 (60%)
Mean age (range, SD, median) 62 years (4–103, 17, 66)
males 61.4 years (4–93, 17, 65)
females 63 years (5–103, 18, 67)
Prior valvular damage 1206 (59.4%)
Bio-prosthesis 231 (11.4%)
Mechanical prosthesis 250 (12.3%)
Pace maker 267 (13%)
Aortic valve damage 544 (34%)
Mitral valve damage 595 (37.3%)
Tricuspid valve damage 64 (4.3%)
History of acute articular rheumatism 156 (9.8%)
Fever 1214 (65.6%)
Services
intensive care unit 86 (4.4%)
cardiology 853 (43.7%)
internal medicine 441 (22.6%)
cardiac surgery 165 (8.5%)
infectious diseases 104 (5.3%)
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when no predictive factor was present to 6 when six predictive
factors or more were present. The rate of endocarditis increased
progressively and signiﬁcantly from 4% (10/256) when no pre-
dictive factor was present (score of 0) to 83% (10/12) when
six predictive factors or more were present (score of 6). The
probability that an IE was present, as measured by the odds
ratio, increased from 1.7 for a score of 1 (the score of 0 being
considered as baseline) to 123 for a score of 6 (Table 5).
In parallel, the PPV rose from 0.06 for a score of 1 to 0.8 for a
score .6. The NPV was 0.96 for a score of 1. The scoring
system gave even better results when it was applied to patients
Table 2. Clinical signs: comparison between IE and rejected cases
Variable
Infective endocarditis
(n ¼ 402)
Rejected cases
(n ¼ 1571)
Relative risk
(95% CI) P
Sex, male 280 (69.7%) 899 (57.3%) 1.6 (1.3–1.9) ,0.000001
Age, mean+SD 63 + 17 61.7 + 17 0.2
Stroke 50 (14.4%) 55 (4.3%) 2.5 (2–3) ,0.0000001
Arthralgia 38 (10%) 121 (9%) 1.1 (0.8–1.5) 0.6
Splenomegaly 41 (11%) 42 (3%) 2.4 (1.9–3) ,0.0000001
Skin rash 14 (4%) 64 (4.7%) 0.8 (0.5–1.3) 0.5
Hepatomegaly 50 (13.3%) 98 (7.3%) 1.6 (1–3.2) 0.0003
Finger clubbing 25 (6.7%) 19 (1.4%) 2.7 (2–3.6) ,0.0000001
Janeway lesion 1 (0.3%) 1 (0.1%) 2.2 (0.6–9) 0.9
Multiple adenopathies 7 (2%) 29 (2.2%) 0.9 (0.5–1.7) 0.9
Spondylodiscitis 14 (4.4%) 16 (1.4%) 2.2 (1.5–3.3) 0.002
Spleen infarction 22 (6.7%) 6 (0.5%) 4 (3.2–5) ,0.0000001
Diarrhoea 25 (6.6%) 52 (4%) 1.5 (1–2) 0.03
Pneumonia 23 (6.2%) 117 (8.8%) 0.7 (0.5–1) 0.1
95% CI, 95% conﬁdence interval.
Table 4. Multivariate analysis
Variable Odds ratio 95% CI P
Sex, male 2.5 1.7–3.6 ,0.00001
Prior valvular damage 8.2 5–13.3 ,0.00001
Fever 2.1 1.4–3 0.003
Stroke 4.3 2.2–8 ,0.00001
Emboli 3.6 1.5–8.6 0.004
Finger clubbing 2.7 1.1–6.7 0.03
Splenomegaly 6 1.4–25 0.02
Leucocytosis 1.6 1.1–2.2 0.01
Thrombocytopenia 2.3 1.4–3.8 0.002
Erythrocyte sedimentation rate .50 1.9 1.3–2.7 0.0006
95% CI, 95% conﬁdence interval.
Hosmer–Lemeshow goodness of ﬁt test: 0.9.
Table 3. Biological results: comparison between IE and rejected cases
Variable
Infective endocarditis
(n ¼ 402)
Rejected cases
(n ¼ 1571)
Relative risk
(95% CI) P
Anemia 199 (54.4%) 507 (39.5%) 1.6 (1.3–1.9) 0.000002
Leucocytosis 171 (45.8%) 399 (30.8%) 1.6 (1.4–1.9) 0.000001
Thrombocytopenia 67 (18.7%) 152 (12%) 1.5 (1.2–2) 0.002
Erythrocyte sedimentation rate .50 204 (64.4%) 492 (43.3%) 2.4 (1.6–2.4) ,0.0000001
95% CI, 95% conﬁdence interval.
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with IE rose from 9.5% for a score of 0 to 100% for a score  5,
and the probability of having IE increased from 2.8 for a score
of 1 to 95 for a score of  5 (Table 6). The PPV also rose in
parallel from 0.2 for a score of 1 to 1 for a score  5 and the
NPV was 0.9 for a score of 1.
Finally, in order to evaluate the diagnosis value of the score,
we drew ROC curves for all cases and for patients with PVD
(Figures 1 and 2). The areas under the ROC curves were 0.753
and 7.03, respectively. Both curves were statistically signiﬁcant
(P, 0.0001).
Prospective cohort study
One hundred and seventeen patients with a suspicion of IE have
been prospectively included in an ongoing cohort study. The
diagnosis of IE was conﬁrmed in 22 patients (19%). The pro-
portion of IE ranged from 0% for a score of 0 to 50% for a
score  5. The area under the ROC curve was 0.72 and the
curve was statistically signiﬁcant (P ¼ 0.01) (Figure 3).
Discussion
The diagnosis of IE remains problematic despite the develop-
ment of standard diagnostic schemes ﬁrst proposed by von
Reyn et al.
20 and subsequently replaced by the modiﬁed Duke
criteria. The incorporation of imaging diagnostic features of IE
by echocardiography in the Duke criteria has greatly improved
the sensitivity and speciﬁcity of these criteria. Another import-
ant progress has been the standardization of the aetiological
diagnosis procedures including systematic serologic testing.
Such strategy has enabled our team to obtain an aetiological
diagnosis within 5 days for 94% of all patients with deﬁnite IE.
2
As a matter of fact, diagnosis of IE is easy when echocardio-
graphic and microbiological evidences are present (major Duke
criteria), but the delay in obtaining these data may in turn delay
the start of empirical therapy that may be critical for this deadly
disease. However, it is important to note that in the same study
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Figure 1. ROC curve including all conﬁrmed and excluded cases of IE.
Table 6. Predictive score of IE: score excluding PVD applied to
patients with PVD
Score
Endocarditis in patients with
prior valvular damage PPV NPV Odds ratio
0 23 (9.5%) 0.045 0.9 baseline 1
1 81 (24%) 0.24 0.9 2.8
2 97 (32.7%) 0.32 0.76 4.6
3 95 (45.7%) 0.46 0.67 8
4 42 (67.7%) 0.68 0.5 20
 5 10 (100%) 1 0.3 95
PPV, positive predictive value; NPV, negative predictive value.
x
2 for trend: P, 0.0000001.
Table 5. Predictive score of IE: overall cases
Score Proportion of IE PPV NPV Odds ratio
0 10 (4%) 0.04 0.93 baseline 1
1 30 (6.5%) 0.06 0.96 1.7
2 99 (18%) 0.2 0.93 5.4
3 113 (28%) 0.28 0.82 9.5
4 97 (44%) 0.44 0.72 19
5 43 (67%) 0.67 0.56 50
 6 10 (83%) 0.83 0.32 123
PPV, positive predictive value; NPV, negative predictive value.
x
2 for trend: P, 0.0000001.
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Figure 2. ROC curve including only patients with PVD.
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procedures performed, leading to extra-costs associated with
unnecessary diagnosis procedures, days of hospitalization and
treatment for patients at a very low risk of endocarditis. For this
reason, and in order to further improve the prognosis of IE by
shortening the delay between suspicion of IE and initiation of
antimicrobial therapy, we performed this cohort study.
Our study shows that several features obtained on admission
including Duke minor criteria, such as predisposing heart con-
dition, vascular phenomena and fever as well as others such
as spleen enlargement or ﬁnger clubbing, and trivial biological
results such as thrombocytopenia, leucocytosis or ESR .50,
were also independently associated with and/or predictive of IE
and may be used to differentiate high risk patients from low risk
patients. Our study also showed that emboli events such as
spondylodiscitis, splenomegaly, intracranial haemorrhage or
members’ arterial emboli were independently associated with
IE. Our model ﬁtted very well with the observed data even
if the major modiﬁed Duke criteria were not included. In a
recent study, Todd et al.
21 have shown that splenomegaly was
an independent predictor of IE, and the proposal by Lamas
et al.
22 to add increased ESR to Duke criteria as well as our
work fuels this hypothesis.
In addition, our study also shows that the greater the number
of predictive factors present, the higher the probability of IE,
and we developed a scoring system enabling us to quantify the
probability of IE. The proportion of IE increased steadily and
concomitantly with the score for both scoring systems, with
even better PPVs when the scoring system was applied to
patients with PVD. Almost one out of every two patients with a
score of 3 had IE and all the patients with a score of  5 had IE.
The simple and easy to calculate score we have developed can
be used to decide in the ofﬁce of the general practitioner or on
admission, for instance, when to speed up diagnosis procedures,
or even initiate empirical antimicrobial therapy. It is also
important to note that despite the fact that our cohort was
heterogeneous in terms of risk factors for IE, as patients with
biological prostheses, mechanical prostheses or pacemakers were
included, this heterogeneity had no impact on the ability of the
scoring system to identify patients with a high probability of
endocarditis. The ROC curves conﬁrmed that our scoring system
accurately separates patients with and without IE. Therefore, our
scoring system, which is based on non-speciﬁc clinical signs and
biological results, may be used to identify patients at high risk
of having IE.
Finally, our results were partly unexpected due to the design
of our study. Because we chose as a control group patients with
rejected endocarditis who were in some way suspected to have
IE, we thought that our results would be biased towards the null
hypothesis, and it was surprising to identify such differences
between patients with IE and patients with rejected IE. For
example, in this study, a male patient presenting with fever and
previous valve lesion having leucocytosis, thrombocytopenia
and ESR .50 has a 74% probability of having IE. Using Duke
criteria at this stage, however, it is impossible to make a possible
IE diagnosis. Therefore, when conﬁrmation of the diagnosis of
IE may take time, a prompt empirical therapy after blood
sampling for culture may help to cure the patient.
The Duke scoring system has been approved and is widely
used. It appears speciﬁc, but its sensitivity depends on the range
and quality of microbiological testing and echocardiography.
2
According to the American Heart Association, the variability in
the clinical presentation of IE requires a diagnostic strategy that
will be both sensitive for disease detection and speciﬁc for its
exclusion across all the forms of the disease.
23 The results of
our study suggest that this aim could be achieved by ﬁrst using a
combination of non-speciﬁc clinical and biological criteria that
should be tested in order to identify both low and high risk
patients, and thereafter speciﬁcally validate or eliminate the
diagnosis made using the major Duke criteria.
However, our study has some limitations, including the fact
that although the collection of the data was prospective, the
study itself was retrospective as it used data that had not been
collected for this purpose. Therefore, the next step will be to
prospectively validate the scoring system in an independent
cohort of patients with suspicion of IE, as the preliminary
results of our prospective study conﬁrmed the results of the
retrospective study.
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